Baek-Yeol Ryoo
MD
Professor of Medical Oncology
👥Biography 个人简介
Baek-Yeol Ryoo at Asan Medical Center contributed to the RESORCE trial establishing regorafenib as the first second-line standard in sorafenib-refractory HCC. His research on treatment sequencing, combination systemic therapies, and biomarkers for HCC treatment response has contributed to the evidence base for management of advanced HCC in Korea and internationally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Baek-Yeol Ryoo 的研究动态
Follow Baek-Yeol Ryoo's research updates
留下邮箱，当我们发布与 Baek-Yeol Ryoo（Asan Medical Center, University of Ulsan）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment